202 related articles for article (PubMed ID: 23728900)
1. Telomerase-specific oncolytic adenovirus: antitumor effects on radiation-resistant head and neck squamous cell carcinoma cells.
Takahashi H; Hyakusoku H; Horii C; Takahashi M; Nishimura G; Taguchi T; Kondo N; Sakakibara A; Urata Y; Sano D
Head Neck; 2014 Mar; 36(3):411-8. PubMed ID: 23728900
[TBL] [Abstract][Full Text] [Related]
2. Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery.
Kuroda S; Fujiwara T; Shirakawa Y; Yamasaki Y; Yano S; Uno F; Tazawa H; Hashimoto Y; Watanabe Y; Noma K; Urata Y; Kagawa S; Fujiwara T
Cancer Res; 2010 Nov; 70(22):9339-48. PubMed ID: 21045143
[TBL] [Abstract][Full Text] [Related]
3. Telomerase-specific virotheranostics for human head and neck cancer.
Kurihara Y; Watanabe Y; Onimatsu H; Kojima T; Shirota T; Hatori M; Liu D; Kyo S; Mizuguchi H; Urata Y; Shintani S; Fujiwara T
Clin Cancer Res; 2009 Apr; 15(7):2335-43. PubMed ID: 19318473
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma.
Kondo N; Tsukuda M; Kimura M; Fujita K; Sakakibara A; Takahashi H; Ishiguro Y; Toth G; Matsuda H
Oncol Rep; 2010 Feb; 23(2):355-63. PubMed ID: 20043095
[TBL] [Abstract][Full Text] [Related]
5. Telomerase-specific virotherapy in an animal model of human head and neck cancer.
Nakajima O; Matsunaga A; Ichimaru D; Urata Y; Fujiwara T; Kawakami K
Mol Cancer Ther; 2009 Jan; 8(1):171-7. PubMed ID: 19139126
[TBL] [Abstract][Full Text] [Related]
6. Use of telomelysin (OBP-301) in mouse xenografts of human head and neck cancer.
Nakajima O; Ichimaru D; Urata Y; Fujiwara T; Horibe T; Kohno M; Kawakami K
Oncol Rep; 2009 Nov; 22(5):1039-43. PubMed ID: 19787218
[TBL] [Abstract][Full Text] [Related]
7. Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines.
Sakakibara A; Tsukuda M; Kondo N; Ishiguro Y; Kimura M; Fujita K; Takahashi H; Matsuda H
Auris Nasus Larynx; 2011 Oct; 38(5):589-99. PubMed ID: 21362583
[TBL] [Abstract][Full Text] [Related]
8. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer.
Li D; Day KV; Yu S; Shi G; Liu S; Guo M; Xu Y; Sreedharan S; O'Malley BW
Cancer Res; 2002 Aug; 62(16):4637-44. PubMed ID: 12183420
[TBL] [Abstract][Full Text] [Related]
9. Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer.
Toivonen R; Suominen E; Grenman R; Savontaus M
Oncol Rep; 2009 Jan; 21(1):165-71. PubMed ID: 19082458
[TBL] [Abstract][Full Text] [Related]
10. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
[TBL] [Abstract][Full Text] [Related]
11. Molecular disruption of the MRN(95) complex induces radiation sensitivity in head and neck cancer.
O'Malley BW; Li D; Carney J; Rhee J; Suntharalingam M
Laryngoscope; 2003 Sep; 113(9):1588-94. PubMed ID: 12972939
[TBL] [Abstract][Full Text] [Related]
12. Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures.
Dias JD; Guse K; Nokisalmi P; Eriksson M; Chen DT; Diaconu I; Tenhunen M; Liikanen I; Grénman R; Savontaus M; Pesonen S; Cerullo V; Hemminki A
Eur J Cancer; 2010 Feb; 46(3):625-35. PubMed ID: 20006487
[TBL] [Abstract][Full Text] [Related]
13. Lister vaccine strain of vaccinia virus armed with the endostatin-angiostatin fusion gene: an oncolytic virus superior to dl1520 (ONYX-015) for human head and neck cancer.
Tysome JR; Wang P; Alusi G; Briat A; Gangeswaran R; Wang J; Bhakta V; Fodor I; Lemoine NR; Wang Y
Hum Gene Ther; 2011 Sep; 22(9):1101-8. PubMed ID: 21361787
[TBL] [Abstract][Full Text] [Related]
14. Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation.
McNally LR; Rosenthal EL; Zhang W; Buchsbaum DJ
Cancer Gene Ther; 2009 Mar; 16(3):246-55. PubMed ID: 18846112
[TBL] [Abstract][Full Text] [Related]
15. Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus (OBP-301) and IL-2 in a mouse model of renal cell carcinoma.
Huang P; Kaku H; Chen J; Kashiwakura Y; Saika T; Nasu Y; Urata Y; Fujiwara T; Watanabe M; Kumon H
Cancer Gene Ther; 2010 Jul; 17(7):484-91. PubMed ID: 20168351
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.
Takakura M; Nakamura M; Kyo S; Hashimoto M; Mori N; Ikoma T; Mizumoto Y; Fujiwara T; Urata Y; Inoue M
Cancer Gene Ther; 2010 Jan; 17(1):11-9. PubMed ID: 19662088
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer.
Liu D; Kojima T; Ouchi M; Kuroda S; Watanabe Y; Hashimoto Y; Onimatsu H; Urata Y; Fujiwara T
Mol Cancer Ther; 2009 Apr; 8(4):980-7. PubMed ID: 19372571
[TBL] [Abstract][Full Text] [Related]
18. Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.
Zumsteg ZS; Morse N; Krigsfeld G; Gupta G; Higginson DS; Lee NY; Morris L; Ganly I; Shiao SL; Powell SN; Chung CH; Scaltriti M; Baselga J
Clin Cancer Res; 2016 Apr; 22(8):2009-19. PubMed ID: 26589432
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of telomerase-specific replication-selective oncolytic viruses for adenoid cystic carcinoma cell lines.
Sato D; Kurihara Y; Kondo S; Shirota T; Urata Y; Fujiwara T; Shintani S
Oncol Rep; 2013 Dec; 30(6):2659-64. PubMed ID: 24065118
[TBL] [Abstract][Full Text] [Related]
20. Telomerase-specific virotherapy for human squamous cell carcinoma.
Fujiwara T
Expert Opin Biol Ther; 2009 Mar; 9(3):321-9. PubMed ID: 19216621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
